Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Surgery Partners has acquired Preferred Vascular Group, a ambulatory surgery business in Tennessee. Preferred Vascular Group provides vascular care services that fit within Surgery Partners’ ambulatory surgery footprint in the state, supporting specialty expansion and referral capture. Surgery Partners acquisitions in the ASC market are focused on adding vascular capabilities to existing outpatient platforms. The announced strategic acquisition is structured as an add on acquisition, with deal size undisclosed, and is part of broader healthcare M&A activity across Tennessee acquisitions.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026